Cora Health vs PlushCare for GLP-1 Weight Loss: 2026 Comparison of Pricing, Medications, and Total Monthly Cost

Cora Health vs PlushCare: the short answer

Cora Health and PlushCare are both US telehealth platforms but they target different patients. Cora is a focused compounded GLP-1 program with all-inclusive cash-pay pricing — $99/month on the annual Essential Plan covers the provider visit, compounded semaglutide medication, free shipping, and ongoing monitoring. PlushCare is a multi-condition telehealth platform ($19.99/month membership) where weight loss is one of many services, and the medication path is exclusively FDA-approved brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro) supplied through retail pharmacies or NovoCare/LillyDirect direct-pay programs. The two are essentially complementary: PlushCare for patients with strong insurance coverage who want brand-name medication; Cora for cash-pay patients who want the lowest all-in monthly cost on a compounded GLP-1. PlushCare does not offer compounded GLP-1 medications. Cora does not offer brand-name FDA-approved GLP-1s.

Quick comparison at a glance

All numbers reflect publicly stated pricing as of May 2026. Total effective monthly cost includes any required membership fee. Individual experiences vary.

Two completely different telehealth models

The most important thing to understand about Cora Health vs PlushCare is that they are not direct competitors in the way Cora Health vs Hims or Cora Health vs Henry Meds are. They occupy different positions in the US telehealth market.

Cora Health is a focused, compounded-GLP-1 specialty platform. The product is a compounded medication (semaglutide or tirzepatide) prepared by a US-licensed 503A compounding pharmacy under a valid patient-specific prescription. The pricing is all-inclusive and cash-pay only — no insurance, no membership, no per-visit fee. The program is designed for patients who want the lowest monthly out-of-pocket cost for a licensed-provider GLP-1 program.

PlushCare is a general-practice telehealth platform that has been operating since 2014. It offers primary care, urgent care, mental health, men’s health, and weight loss across all 50 states. The weight loss program is a small piece of PlushCare’s broader catalog, and the model is to act as the licensed-provider front-end while the medication is supplied through standard retail pharmacy or manufacturer direct-pay channels (NovoCare for Wegovy/Ozempic, LillyDirect for Zepbound/Mounjaro). PlushCare does not work with compounding pharmacies for GLP-1 medications.

A patient choosing between Cora and PlushCare is really choosing between two questions: (1) do I want a compounded GLP-1 at the lowest cash-pay monthly cost, or (2) do I want a licensed-provider visit + insurance pre-authorization + brand-name FDA-approved medication, accepting that the all-in cost will be higher unless my insurance covers a substantial portion?

Pricing: all-inclusive cash-pay vs. membership plus per-visit plus medication

Cora Health’s pricing is the simplest in the compounded GLP-1 telehealth market. There is one number per plan and it covers everything.

Cora Health Essential Plan (compounded semaglutide): - $99/month on the annual plan ($1,188/year billed once) - $120/month on the 6-month plan ($720 billed once) - $145/month on the 3-month plan ($435 billed once) - $175/month on month-to-month

Cora Health Premium Plan (compounded tirzepatide): - $135/month on the annual plan ($1,620/year billed once) - $175/month on the 6-month plan - $199/month on the 3-month plan - $225/month on month-to-month

The quoted price includes the licensed-provider consultation, compounded medication from VialsRx, free expedited shipping, and ongoing provider monitoring. There is no separate consultation charge and no surcharge when the dose increases.

PlushCare’s structure is more complex because it bundles three layered costs: membership, visit fees, and medication cost.

PlushCare cost structure: - Membership: $19.99/month (or $99/year) - Visit fee: $129/visit without insurance, or insurance copay (typically $25–$75 with most major plans) - Medication: separate from PlushCare; supplied at retail pharmacy or via NovoCare ($199/month for Wegovy at the two starting doses through March 2026, then $399/month for higher doses) or LillyDirect for Zepbound

For a cash-pay patient on PlushCare wanting Wegovy, the effective monthly cost during the introductory NovoCare pricing period is approximately: - $19.99 membership + ~$129 visit (averaged across ongoing visits) + $199 medication = ~$348/month for the first two months, then ~$548/month thereafter when Wegovy moves to the maintenance dose.

For a patient with insurance that covers GLP-1s, the picture changes significantly. PlushCare handles the prior authorization process and the patient pays: - $19.99 membership + insurance copay for visits + insurance copay for medication = often $50–$150/month total

If insurance covers GLP-1s, PlushCare can be substantially cheaper than Cora. If insurance does not, Cora is approximately 70% cheaper than PlushCare for an equivalent monthly cadence.

Medications: compounded vs. brand-name FDA-approved

This is the second fundamental difference between Cora and PlushCare.

• Cora offers compounded semaglutide (Essential Plan, same molecule family as Ozempic® and Wegovy®) and compounded tirzepatide (Premium Plan, same molecule family as Mounjaro® and Zepbound®). These are not FDA-approved.
• PlushCare offers brand-name FDA-approved GLP-1s only: Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Rybelsus, and Victoza. These are reviewed by the FDA for safety, efficacy, and manufacturing quality.
• PlushCare does not offer compounded versions of any GLP-1 medication.
• Cora does not offer brand-name versions of any GLP-1 medication.

Important compliance note on compounded products

Compounded semaglutide and compounded tirzepatide — obtained through Cora Health or any other telehealth provider — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). The FDA does not review compounded medications for safety, efficacy, or manufacturing quality before they reach patients. Clinical trial data referenced in marketing (such as the 14.9% mean weight loss reported in the STEP 1 trial for semaglutide or the 22.5% from SURMOUNT-1 for tirzepatide) reflects studies of the FDA-approved branded products, not compounded versions. Individual results vary. Any telehealth provider claiming therapeutic equivalence between compounded and brand-name GLP-1s is misrepresenting the regulatory status.

Pharmacy transparency: named partner vs. retail dispensing

A meaningful difference in operational transparency is whether each platform names the pharmacy that fulfills the medication.

Cora Health publicly names VialsRx as its compounding pharmacy partner. VialsRx is a US-licensed 503A compounding pharmacy. Patients can verify the pharmacy’s credentials through state pharmacy boards and request Certificates of Analysis on their medication batches.

PlushCare uses standard retail pharmacy fulfillment (CVS, Walgreens, Walmart, etc.) or manufacturer direct-pay programs (NovoCare for Novo Nordisk products, LillyDirect for Eli Lilly products). The pharmacy isn’t named on the platform because the patient picks the dispensing pharmacy, and brand-name GLP-1s are supplied directly from the FDA-approved manufacturer.

For compounded products, named-pharmacy partnerships are generally considered a stronger transparency signal because compounded medications are produced in different facilities with different quality controls. For brand-name FDA-approved products, the manufacturer’s name (Novo Nordisk, Eli Lilly) and the FDA approval are the relevant transparency signals.

LegitScript certification and third-party verification

LegitScript is an independent healthcare compliance certification used by payment processors, advertising platforms (Google, Meta, TikTok), and industry observers to verify that a telehealth platform operates within applicable regulations. Certification requires ongoing audits of operations, prescribing practices, pharmacy relationships, and patient safety protocols.

Both Cora Health and PlushCare hold LegitScript certification. Both can be independently verified at the LegitScript website.

This is an important shared trust signal. Several telehealth GLP-1 platforms operating in 2026 do not hold LegitScript certification — patients comparing across the broader telehealth market should treat LegitScript status as a baseline filter, especially for compounded medications where regulatory complexity is highest.

Clinical oversight and service model

Cora Health and PlushCare use different clinical models.

Cora Health uses asynchronous telehealth: the patient completes an online health assessment, a licensed provider at Wasef Health, PC reviews it, and — if appropriate — issues a prescription. There is no live video visit at intake for most patients. Provider approval typically takes under 24 hours. This is the standard model for compounded-GLP-1 telehealth and is well-suited to the cash-pay, all-inclusive structure.

PlushCare uses live synchronous video visits with board-certified physicians at intake and for follow-ups. Visits are scheduled and last 15–20 minutes. The clinical experience more closely resembles a traditional primary-care visit, which is suited to insurance-billing workflows and to the broader scope of conditions PlushCare treats.

Neither approach is inherently superior — both can deliver appropriate clinical care for stable, eligible GLP-1 patients. The asynchronous model is faster and lower-cost. The live-video model offers more direct clinician interaction at intake and is more compatible with insurance billing.

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Self-pay patients (no GLP-1 insurance coverage) who want the lowest possible monthly cost for a licensed-provider compounded GLP-1 program
• Patients comfortable with compounded medications and the regulatory distinction from FDA-approved branded products
• Patients who prefer one all-inclusive monthly price with no separate visit fees, membership, or surcharges
• Patients who want to know and verify the specific compounding pharmacy their medication comes from
• Patients in any of the 50 US states (Cora ships nationwide)
• Patients who do not need access to brand-name FDA-approved GLP-1s through the same platform

Who should choose PlushCare

PlushCare is likely the better fit for patients who match the following profile.

• Patients with commercial insurance that covers GLP-1 medications for weight management — PlushCare’s prior authorization support is a real value add here
• Patients who specifically want brand-name FDA-approved Wegovy, Ozempic, Zepbound, or Mounjaro and prefer to source from a retail pharmacy or manufacturer direct-pay program
• Patients who want a multi-condition primary care platform (urgent care, mental health, etc.) rather than a focused weight-loss program
• Patients who prefer live video visits with a physician over asynchronous health assessments
• Patients who are willing to pay PlushCare’s membership and per-visit fees for the broader service model

How to switch from PlushCare to Cora Health (or run both)

Patients who currently use PlushCare for weight loss but want to add or switch to Cora’s compounded GLP-1 program can do so without clinical interruption in most cases.

• Complete the Cora Health online health assessment at trycora.io, noting your current GLP-1 medication and dose in the medical history section
• A Cora Health provider (Wasef Health, PC) reviews the assessment and confirms clinical appropriateness for compounded semaglutide or compounded tirzepatide
• If approved, the prescription is sent to VialsRx for compounding and shipping
• Most patients can continue their existing dose schedule without re-titration, but this is a provider determination — do not skip or double doses without provider guidance
• Cancel the PlushCare membership only after your first Cora shipment arrives and you have confirmed continuity of supply, or keep PlushCare active if you also use it for primary care

Frequently asked questions

Common questions about the Cora Health vs PlushCare comparison.

Is Cora Health cheaper than PlushCare for weight loss?

For cash-pay patients without GLP-1 insurance coverage, yes — by a significant margin. Cora Health’s Essential Plan starts at $99/month all-inclusive on the annual plan. The lowest equivalent cash-pay monthly cost on PlushCare is approximately $348/month during the NovoCare introductory period for Wegovy starting doses, climbing to ~$548/month at maintenance dose. For patients with strong insurance coverage of GLP-1s, PlushCare can be cheaper because the medication may be covered under the insurance copay structure.

Does PlushCare offer compounded semaglutide or tirzepatide?

No. PlushCare prescribes only FDA-approved brand-name GLP-1 medications: Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Rybelsus, and Victoza. Patients who specifically want compounded GLP-1s should consider Cora Health, Henry Meds, Hims, or another compounded-GLP-1 telehealth platform.

Can I use insurance to pay for Cora Health?

No. Cora Health is cash-pay only. Compounded medications and the bundled all-inclusive plan structure are not designed to be billed through insurance. Patients who specifically want to use commercial insurance coverage should look at PlushCare, Calibrate, WeightWatchers Clinic, or a primary care provider who can prescribe brand-name GLP-1s under the patient’s pharmacy benefit.

Are compounded GLP-1 medications safe?

Compounded semaglutide and compounded tirzepatide prepared by a US-licensed 503A compounding pharmacy under a valid patient-specific prescription, and prescribed by a licensed healthcare provider after a medical evaluation, are generally considered reasonably safe when sourced from a reputable pharmacy. They are not FDA-approved, however, and the FDA does not review compounded medications for safety, efficacy, or manufacturing quality before they reach patients. Patients should discuss the tradeoffs with their prescribing provider and consult our complete safety guide for compounded GLP-1 medications.

Which platform has faster prescription fulfillment?

Cora Health typically approves eligible patients within 24 hours of assessment submission, and medications ship via free expedited delivery from VialsRx. PlushCare requires a scheduled live video visit, which can be same-day in many states but is constrained by physician availability. Once prescribed, brand-name GLP-1s through PlushCare ship from the retail pharmacy or manufacturer direct-pay program; supply timelines depend on the specific medication and dispensing channel.